Kitchener HC - Search Results

1

Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis.

Cruickshank ME, Buchan S, Melvin WT, Kitchener HC. Cruickshank ME, et al. Among authors: kitchener hc. Br J Obstet Gynaecol. 1999 Sep;106(9):969-76. doi: 10.1111/j.1471-0528.1999.tb08439.x. Br J Obstet Gynaecol. 1999. PMID: 10492111 Clinical Trial.

2

Serial quantitation of HPV-16 in the smears of women with mild and moderate dyskaryosis.

Flannelly G, Jiang G, Anderson D, Melvin W, Mann E, Kitchener H. Flannelly G, et al. J Med Virol. 1995 Sep;47(1):6-9. doi: 10.1002/jmv.1890470103. J Med Virol. 1995. PMID: 8551261

3

Fertility and pregnancy outcome following large loop excision of the cervical transformation zone.

Cruickshank ME, Flannelly G, Campbell DM, Kitchener HC. Cruickshank ME, et al. Among authors: kitchener hc. Br J Obstet Gynaecol. 1995 Jun;102(6):467-70. doi: 10.1111/j.1471-0528.1995.tb11319.x. Br J Obstet Gynaecol. 1995. PMID: 7632638

4

The 1993 British Society for Colposcopy and Cervical Pathology/National Coordinating Network United Kingdom Colposcopy Survey. Comparison with 1988 and the response to introduction of guidelines.

Kitchener HC, Cruickshank ME, Farmery E. Kitchener HC, et al. Br J Obstet Gynaecol. 1995 Jul;102(7):549-52. doi: 10.1111/j.1471-0528.1995.tb11359.x. Br J Obstet Gynaecol. 1995. PMID: 7647057

5

Towards optimal management of the mildly abnormal smear.

Cruickshank ME, Kitchener HC. Cruickshank ME, et al. Among authors: kitchener hc. Curr Opin Obstet Gynecol. 1995 Feb;7(1):20-3. Curr Opin Obstet Gynecol. 1995. PMID: 7742510 Review.

6

Can HPV16 detection rationalise the management of women with mild or moderate dyskaryosis?

Buchan S, Jiang G, Cruickshank ME, Melvin WT, Kitchener HC. Buchan S, et al. Among authors: kitchener hc. Biochem Soc Trans. 1996 May;24(2):251S. doi: 10.1042/bst024251s. Biochem Soc Trans. 1996. PMID: 8736909 No abstract available.

7

The case for stopping cervical screening at age 50.

Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. Cruickshank ME, et al. Among authors: kitchener hc. Br J Obstet Gynaecol. 1997 May;104(5):586-9. doi: 10.1111/j.1471-0528.1997.tb11537.x. Br J Obstet Gynaecol. 1997. PMID: 9166202

8

Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical disease.

Cruickshank ME, Chambers G, Murray G, McKenzie L, Donaldson C, Andrew J, Campbell MK, Kitchener HC. Cruickshank ME, et al. Among authors: kitchener hc. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):735-40. doi: 10.1046/j.1525-1438.2002.01116.x. Int J Gynecol Cancer. 2002. PMID: 12445251

9

HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia.

Kitchener HC, Walker PG, Nelson L, Hadwin R, Patnick J, Anthony GB, Sargent A, Wood J, Moore C, Cruickshank ME. Kitchener HC, et al. BJOG. 2008 Jul;115(8):1001-7. doi: 10.1111/j.1471-0528.2008.01748.x. Epub 2008 May 22. BJOG. 2008. PMID: 18503572

10

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

Skinner SR, Szarewski A, Romanowski B, Garland SM, Lazcano-Ponce E, Salmerón J, Del Rosario-Raymundo MR, Verheijen RH, Quek SC, da Silva DP, Kitchener H, Fong KL, Bouchard C, Money DM, Ilancheran A, Cruickshank ME, Levin MJ, Chatterjee A, Stapleton JT, Martens M, Quint W, David MP, Meric D, Hardt K, Descamps D, Geeraerts B, Struyf F, Dubin G; VIVIANE Study Group. Skinner SR, et al. Lancet. 2014 Dec 20;384(9961):2213-27. doi: 10.1016/S0140-6736(14)60920-X. Epub 2014 Sep 1. Lancet. 2014. PMID: 25189358 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page